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Abstract: The purpose of this study was to investigate the presence of β-lactam-resistant 
bacteria in six different types of Portuguese cheese. The numbers of ampicillin resistant 
(AMP
r) bacteria varied from 4.7  10
2 to 1.5  10
7 CFU/g. Within 172 randomly selected 
β-lactam-resistant bacteria, 44 resistant phenotypes were found and 31.4% were multidrug 
resistant. The majority (85%) of the isolates identified belonged to the Enterobacteriaceae 
family. The presence of the blaTEM gene was detected in 80.9% of the tested isolates. The 
results suggest that without thermal processing of the milk and good hygienic practices, 
cheese may act as a vehicle of transfer of β-lactam-resistant bacteria to the gastrointestinal 
tract of consumers. 
Keywords: Ready-to-eat (RTE) food; cheese, minimal inhibitory concentration (MIC); β-
lactam-resistant Enterobacteriaceae; multiplex-PCR; blaTEM gene.  
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1. Introduction  
Antimicrobials are natural or synthetic drugs which inhibit or kill bacteria. This ability makes them 
unique for the control of deadly infectious diseases caused by a large variety of pathogenic bacteria 
[1]. Acquired antimicrobial resistance is particularly problematic and can limit treatment options, 
contributing to more pain and increased deaths. In humans, most of the rising antimicrobial resistance 
results from the overuse and misuse of antimicrobials by patients and health personnel. The 
widespread use of antimicrobials outside human medicine is another serious concern. In fact, 
antimicrobials have also been used increasingly in plant biotechnology and in animals, for the 
treatment of bacterial disease or as growth-enhancing compounds in intense husbandry [2]. 
Antimicrobials-resistant bacteria also occur in some retail meats and poultry and in diverse other types 
of food, including ready-to-eat (RTE) [3].  
Among the newly-emerging resistant bacteria transmitted to humans, mainly via meat and other 
food of animal origin are the members of the family Enterobacteriaceae [3]. This family comprises a 
large group of Gram-negative, non-spore-forming, facultative anaerobic bacteria. Enterobacteriaceae 
are often associated with poor hygiene practices in the manipulation of foods of animal origin, but they 
may themselves represent the natural flora of the food. Milk and dairy products contain 
Enterobacteriaceae at variable levels. In some cheese-making processes these bacteria can contribute 
to flavour and texture, but their presence, particularly at high levels, may be less desirable owing to 
their ability to cause spoilage [4]. 
Different antimicrobial resistance mechanisms have been described [5-7]. One of them is the 
presence of hydrolytic enzymes, such as the β-lactamases that cleave β-lactam antibiotics. Rates of 
bacterial resistance to antimicrobial agents are increasing worldwide and the production of β-
lactamases is the most common mechanism of bacterial resistance [8,9]. Different types of β-
lactamases have been reported in different genera of Gram negative bacillary bacteria, with a high 
prevalence in members of the family Enterobacteriaceae.  The two types of β-lactamases that are 
associated to most of the increasing multidrug resistance are the class C enzymes and the extended-
spectrum class A enzymes, namely the chromosomal-encoded AmpC β-lactamases and the plasmid 
encoded extended-spectrum β-lactamases (ESBL) [10]. AmpC β-lactamases are expressed 
constitutively at very low levels and generally do not contribute to β-lactam resistance. However, in 
some Enterobacteriaceae (Serratia marcescens, Citrobacter freundii,  Morganella morganii, 
Providencia stuartii and especially Enterobacter cloacae) AmpC β-lactamases can be induced in the 
presence of a β-lactam or as a result of regulatory gene mutations [11]. Nevertheless, other 
Enterobacteriaceae such as Escherichia coli,  Klebsiella pneumoniae, have been described as 
harbouring plasmid AmpC β-lactamases [12]. Mesa et al. (2006) [13], reported a prevalence of 31.1% 
of resistant Enterobacteriaceae among food outbreaks with 4.4% to 66.6% of carriers within each 
outbreak. These data reinforce the hypothesis that ESBL producing Enterobacteriaceae could be 
transmitted to humans by the food supply, particularly by the consumption of RTE food that are eaten 
without being cooked, such as cheese. Nevertheless, resistance to β-lactams has also been reported in 
non-Enterobacteriaceae bacteria such as Pseudomonales [14]. The aim of this study was an 
investigation of the presence of antimicrobial resistance to broad spectrum β-lactams within bacteria 
isolated from different types of Portuguese cheese.  Int. J. Mol. Sci. 2009, 10                 
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2. Experimental Section 
2.1. Sampling  
Twenty cheese samples, corresponding to six different types of Portuguese soft and semi-soft 
ripened cheeses were used. Table 1 shows the origin and the occurrence of thermal processing of the 
milk. The cheeses were random collected in 2007, at retail establishments in different regions, from the 
North to the South of Portugal. From each cheese, an aliquot of 25 g (which included approximately 
equal amounts of material from the inner and outer parts of the cheese) was removed and blended for 2 
min, in a Stomacher
 (Barcelona, Spain), with 225 mL of buffered peptone water (BPW) (pH 7.0) 
supplemented with 50 g/mL cycloheximidine (Sigma, Saint Louis, USA).  
Table 1. Characterization of the cheeses analyzed with respect to the origin and thermal 
processing of the milk. 
Type of cheese 
Milk  Number of 
cheeses  Origin  Thermal processing 
  A
 ewe  no  2 
B ewe no  13 
C goat no  2 
D goat  pasteurization  1 
E cow  pasteurization  1 
F 
mixture  
(cow, ewe and goat) 
no 1 
 DOP (Denomination of Protected Origin). 
2.2. Enumeration of ampicillin resistant bacteria  
The enumeration of AMP
r bacteria was performed on five cheese samples randomly selected from 
five types of cheese (A, B, C, D and F). Portions of 0.1 mL of the homogenised or of the appropriately 
diluted cheese samples in BPW containing 50 g/mL cycloheximidine, obtained as described above, 
were immediately surface plated onto three replicate plates of VRBG (Violet Red Bile Glucose) agar 
(Oxoid, Hampshire, England) supplemented with 20 g/mL of sodium ampicillin (AppliChem, 
Damstadt, Germany). Plates were incubated aerobically at 37 ºC for 38 h before counting the colonies. 
Although this medium is used to select for Enterobacteriaceae, all the AMP
r isolates were counted. 
2.3. Detection of ampicillin resistant bacteria  
In order to recover all the resistance phenotypes present in the cheeses, even stressed ones due to 
milk and/or cheese processing, after sampling each one of the twenty homogenised cheese samples 
were overnight incubated at 37 ºC, before surface plating on VRBG and on SS (Salmonella & 
Shigella) agar (Oxoid, Hampshire, England). Both media were supplemented with 20 g/mL of 
sodium ampicillin (AppliChem, Damstadt, Germany). Plates were incubated aerobically at 37 ºC for 
24 to 48 h. Different morphological types of AMP
r colonies were selected and replicated five times for 
phenotypic confirmation. Strains Escherichia coli XL1-Blue and Escherichia coli XL1-Blue Int. J. Mol. Sci. 2009, 10                 
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transformed with plasmid pUC18 (which contains the TEM-1 β-lactamase gene) were used as negative 
and positive controls, respectively for AMP
r phenotype identification. 
2.4. Nitrocefin test and antimicrobial susceptibility tests 
The detection of -lactamases produced by the AMP
r isolates was performed by adding nitrocefin 
(Oxoid, Hants, England) to the cell biomass, according to the manufacturer instructions. For the 
positive nitrocefin strains, the susceptibility pattern determination was performed by the disk diffusion 
method (DDM) on Mueller Hinton agar (Oxoid, Hampshire, England) with antibiotic disks (Oxoid, 
Hampshire, England) according to the Clinical Laboratory Standards Institute (CLSI), formerly 
National Centre Clinical Laboratory Standards (NCCLS) [15,16]. Thirteen different antibiotics were 
used: amoxicillin/clavulanic acid combination (Clavamox) (AMC) 30 g/10  g, respectively; 
ceftazidime (CAZ) 30 g; cefotaxime (CTX) 30 g; cefpirome (CPO) 30 g; aztreonam (ATM) 30 g; 
cefoxitin (FOX) 30 g; imipenem (IPM) 10 g; meropenem (MEM) 10 g; chloramphenicol (CHL) 
30 g; tetracycline (TET) 30 g; gentamicin (GEN) 10 g; trimethoprim/sulfamethoxazol (Bactrim; 
SXT) combination (1:19) and ciprofloxacin (CIP) 5 g.  
In order to observe the influence of clavulanic acid on both CAZ and CTX, these antibiotics were 
positioned in line, with (AMC) in the middle. The results of the antimicrobial susceptibilities were 
interpreted according to the CLSI guidelines. 
2.5. Bacterial identification  
The identification of sixty β-lactamase producing isolates randomly selected from VRBG and SS 
plates was carried out in two steps. Firstly, classical morphological and physiological tests were 
performed in agreement with the Bergey´s Manual of Determinative Bacteriology [17]. These tests 
included Gram staining reaction, morphology, motility, and biochemical tests including: 
fermentative/oxidative metabolism of glucose [18] (fermentation of glucose to acid or to acid and gas), 
aerobic/anaerobic growth, catalase and oxidase reactions. Subsequently, the isolates identified as 
belonging to the Enterobacteriaceae family were submitted to additional identification by using the 
miniaturized Enterosystem 18R galleries (Liofilchem Bacteriology Products, Roseto, Italy), following 
the manufacturer instructions. Enterosystem 18 R system is based on the metabolism of ortho-
nitrophenol (ONPG), lysine, ornithine, arginine-decarboxylase, phenilalanine-deaminase, citrate, 
malonate, urease test, H2S, and Voges-Proskauer reaction, indol test and in the fermentation of 
glucose, mannitol, inositol, sorbitol, sucrose, arabinose and raffinose.  
2.6. β-lactamase genes 
The identification of the genes involved in β-lactam resistance was performed, in 21 random 
selected β-lactamase producing isolates, by a multiplex-PCR approach for three β-lactamase (bla) 
genes (blaTEM, blaSHV and blaCTX-M) according to Monstein et al. [19], except that genomic DNA was 
extracted by the guanidine thiocyanate method according to Pitcher et al. [20].  Int. J. Mol. Sci. 2009, 10                 
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Strains  E. coli UB0402407 and K. pneumoniae HY0301692, kindly provided by the Clinical 
Microbiology Department, Linköping University, Sweden, were used as positive controls for blaTEM + 
blaCTX-M genes and blaSHV gene, respectively. 
3. Results and Discussion  
3.1. Enumeration of ampicillin resistant bacteria  
The enumeration of ampicillin resistant bacteria was performed on VRBG agar, a medium for the 
detection and enumeration of bile-tolerant Enterobacteriaceae in dairy products and foods, that is 
becoming a preferred medium for use in investigations into raw materials, processed foods and plant 
hygiene. Figure 1 shows the counting data of AMP
r bacteria on VRBG plates, relative to five cheeses 
samples corresponding to five different types of cheese (A, B, C, D and F, Table 1). According to the 
type of cheese, the numbers of AMP
r varied from about 4.7  10
2 CFU/g to 1.5  10
7 CFU/g.  
Figure 1. Mean values of ampicillin resistant (AMP
r) bacteria (CFU/g of cheese) ± the 
standard deviation (error bars), on VRBG agar medium, after 38 hours at 37 ºC. 
 
Although Enterobacteriacea are used as a parameter in process hygiene criteria for various food 
products, current legislation in Europe does not use Enterobacteriaceae as microbiological criteria for 
cheese made from raw milk. Nevertheless, in cheeses made from pasteurized milk the level of 
contamination with E. coli may not exceed 10
3 CFU/g [21]. Various genera of Enterobacteriaceae are 
commonly found in milk and cheese [4], although the highest counts close to 10
7 CFU/g were 
generally found during the first days of ripening, decreasing afterwards [22]. In this work, the numbers 
of AMP
r bacteria varied according to the type of cheese (Figure 1). The lowest values were obtained 
for cheese types A (3.0  10
3 CFU/g) and D (4.7  10
2 CFU/g). The first is a DOP (Denomination of 
Protected Origin) cheese made from raw ewe’s milk, the second is a cheese made from pasteurized 
goat’s milk (Table 1). The results from the counts in cheese type A are an example that it is possible to 
produce good quality cheese with raw milk. The results from cheese type D, made from pasteurized 
goat’s milk confirm that the thermal processing of the milk is an important factor to decrease bacterial 
contaminations. Nevertheless, to rely only on pasteurization to solve bacterial contaminations is likely 
to limit efforts to improve total hygiene in cheese production. Int. J. Mol. Sci. 2009, 10                 
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The highest level was obtained for type C cheese made from raw goat’s milk (1.5  10
7 CFU/g). 
Since the majority (85%) of the isolates identified belonged to the Enterobacteriaceae family, the 
suggested level of contamination of the cheese from type C, deduced from the presented data,   
is concerning.  
In order to avoid high rates of cheese contamination with these and other potential hazardous 
bacteria, the existence of good sanitary conditions during milking and cheesemaking is obligatory. 
This includes herd health management, particularly udder health preventive management, hygiene of 
milking, promptly and properly refrigeration of the milk after milking and hygiene along the cheese 
production chain. 
3.2. Detection of -lactam-resistant bacteria 
The detection of AMP
r bacteria in cheeses was performed by using VRBG agar and SS agar. In both 
media, the growth of gram-positive microorganisms is inhibited due to the presence of either pure bile 
salts, mixtures of bile salts or dyes. SS agar has been developed for the selection and differentiation of 
enteric microorganisms, from clinical and nonclinical materials.  
Table 2. Identification of 60 AMP
r isolates positive for the nitrocefin test, and respective 
type of cheese and recovery medium. 
Legend: Medium VRBG – Violet Red Bile Glucose; Medium SS – Salmonella/Shigella. NI – Not identified.  
Family/Genus Species 
Number of 
isolates 
% 
Type of 
cheese 
Recovery 
medium 
Enterobacteriaceae  NI  17  28.3  A, B, C, D  VRBG, SS
Proteus vulgaris  9  15.0  B, C, F  VRBG, SS
Escherichia coli  6  10.0  B, D, F  VRBG, SS
Morganella 
morganii 
6  10  B, C, F  VRBG, SS
Enterobacter 
cloacae 
4  6.7  A, B, F  VRBG 
Proteus mirabilis  2 3.3  B,  F  VRBG 
Serratia rubidaea  2 3.3  A  SS 
Citrobacter 
freundii 
1 1.7  B VRBG 
Enterobacter 
sakazakii 
1 1.7  B VRBG 
Enterobacter 
alvei 
1 1.7  B VRBG 
Providencia 
retgeri 
1 1.7  B  SS 
Shigella boydii  1 1.7  D  SS 
Pseudomonas spp. NI  5  8.3  B, C  VRBG, SS
Aeromonas spp.  NI  4  6.7  B, C, D  VRBG, SS
All   60  100 
A, B, C, 
D, F 
VRBG, SSInt. J. Mol. Sci. 2009, 10                 
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A total of 182 AMP
r selected isolates recovered from VRBG and from SS plates were screened for 
the presence of -lactamases by the nitrocefin test. From the 182 isolates, 172 were found positive 
(102 from VRBG and 70 from SS plates) indicating the presence of -lactamases in 94.5% of the 
AMP
r isolates. The three isolates selected from cheese type E (made from pasteurized cow’s milk) 
were within the 10 nitrocefin negative isolates. 
Concerning the suitability of both media to recover β-lactam-resistant bacteria, the results showed 
that both media fulfilled this objective. From a total of sixty β-lactamase producers submitted to 
identification, only three (6.7% of the isolates) and five (15% of the isolates) species were recovered 
only from SS or from VRBG plates, respectively (Table 2).  
3.3. Bacterial identification  
Sixty nitrocefin positive isolates (37 from VRBG and 23 from SS plates) were identified as 
belonging to the Enterobacteriaceae family (85%) and to the genera Pseudomonas  (8.3%) and 
Aeromonas (6.7%) (Table 2). Within the Enterobacteriaceae family, 34 isolates (12 from SS and 22 
from VRBG plates) were identified as belonging to eleven different species. It was not possible to 
identify at species level 17 Enterobacteriaceae isolates (28.3%) recovered from both media. The type 
cheese B, made from raw ewe’s milk (Table 1) was the source of most of the identified isolates. 
However 13 out of the 20 cheeses analyzed were from this type. Five different enterobacterial species 
were collected from type cheese F (made from a raw milk mixture from cow, ewe and goat) although a 
single cheese was analyzed. Regarding the recovery medium, from the eleven identified species, five 
(Enterobacter cloacae,  Proteus mirabilis,  Citrobacter freundii,  Enterobacter sakasakii and 
Enterobacter alvei) and three (Serratia rubidaea, Providencia retgeri and Shigella boydii) species 
were only collected from VRBG or SS plates, respectively (Table 2). Pseudomonas and Aeromonas 
isolates were recovered from both media.  
3.4. Antimicrobial susceptibility tests 
The results from antimicrobial susceptibility determination for the 13 antimicrobial agents and the 
respective percentage of the resistance phenotypes obtained showed a higher resistance to AMC 
(51.7%) and FOX (46.5%) and to TET (46.5%) (Table 3).  
It is also noticed a high resistance level (38.4 %) to SXT. Nevertheless, antimicrobial agents which 
seem more effective, thus having higher susceptibility among these bacterial strains are GEN (98.3%), 
CIP (97.7%), IPM (95.3%) and MEM (90.7%) (Table 3). In this study, a multidrug resistance (MDR) 
phenotype was defined for isolates that were resistant to two or more structurally unrelated 
antimicrobial agents. According to this, 31.4% of the different phenotypes detected displayed a MDR 
phenotype (Table 4). The most prevalent resistant phenotypes have patterns of SXT and/or TET plus 
AMC and FOX and finally CHL.  
 Int. J. Mol. Sci. 2009, 10                 
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Table 3. Minimal inhibitory concentrations (MIC) 
a) for the antimicrobial agents tested and 
percentage of the resistance or susceptible phenotype obtained among the isolated 
AMP
r/nitrocefin positive strains (n = 172). 
 
 Susceptible  Resistant 
Antimicrobial agent 
Φ MIC
 a)   %  Φ MIC
 a) n  % 
(mm) (µg/mL) n  (n = 172)  (mm)  (µg/mL)    (n = 172) 

 
-
 
l
a
c
t
a
m
s
 
AMC (30:10 µg)  ≥ 18  ≤ 8/4  67  39.0  ≤ 13  ≥ 32/16  89  51.7 
FOX (30 µg)  ≥ 18  ≤ 8  70  40.7  ≤ 14  ≥ 32  80  46.5 
CTX (30 µg)  ≥ 23  ≤ 8  115  66.9  ≤ 14  ≥ 32  23  13.4 
CPO (30 µg)  ≥ 18  ≤ 8  150  87.2  ≤ 14  ≥ 32  10  5.8 
ATM (30 µg)  ≥ 22  ≤ 8  142  82.6  ≤ 15  ≥ 32  10  5.8 
CAZ (30 µg)  ≥ 18  ≤ 8  158  91.9  ≤ 14  ≥ 32  9  5.2 
MEM (10 µg)  ≥ 16  ≤ 4  156  90.7  ≤ 13  ≥ 16  9  5.2 
IPM (10 µg)  ≥ 16  ≤ 4  164  95.3  ≤ 13  ≥ 16  2  1.2 
N
o
n
 

 
–
 
l
a
c
t
a
m
s
 
TET (30 µg)  ≥ 19  ≤ 4  56  32.6  ≤ 14  ≥ 16  80  46.5 
SXT (1:19 µg)  ≥ 16  ≤ 2/38  103  59.9  ≤ 10  ≥ 8/152  66  38.4 
CHL (30 µg)  ≥ 18  ≤ 8  108  62.8  ≤ 12  ≥ 32  35  20.3 
GEN (10 µg)  ≥ 15  ≤ 4  169  98.3  ≤ 12  ≥ 8  3  1.7 
CIP (5 µg)  ≥ 21  ≤ 1  168  97.7  ≤ 15  ≥ 4  0  0.0 
a)  MIC values were determined after conversion of the respective diameters obtained from the disc diffusion 
antimicrobial susceptibility testing from CLSI standards [15,16]. 
Table 4. Prevalence of resistance phenotypes to major antimicrobial classes among 172 
nitocefin positive isolates. 
 Resistance  Phenotype 
Number of 
isolates 
% 
M
u
l
t
i
d
r
u
g
 
r
e
s
i
s
t
a
n
t
 
(
M
D
R
)
 
p
h
e
n
o
t
y
p
e
s
 
  AMP, SXT, TET  8  4.65 
AMP, AMC, FOX, SXT, TET  8  4.65 
AMP, AMC, FOX, CHL, TET  7  4.07 
AMP, AMC, FOX, CHL, SXT, TET  4  2.33 
AMP, AMC, FOX, CHL, SXT  4  2.33 
AMP, AMC, CHL, TET  2  1.16 
AMP, CHL, SXT, TET  2  1.16 
AMP, AMC, SXT, TET  2  1.16 
AMP, AMC, CHL, SXT, TET  2  1.16 
AMP, AMC, FOX, CEPH3, CPO, CHL, SXT, 
TET 
2 
1.16 
AMP, CHL, TET  2  1.16 
AMP, FOX, CHL, TET  2  1.16 
Others with only one representative  9  5,22 
Sub-total   54  31.40 
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Table 4. Cont. 
 Resistance  Phenotype 
Number of 
isolates 
% 
N
o
n
-
m
u
l
t
i
d
r
u
g
 
r
e
s
i
s
t
a
n
t
 
(
M
D
R
)
 
p
h
e
n
o
t
y
p
e
s
 
  AMP 38  22.09 
AMP, TET  19  11.05 
AMP, AMC, FOX, SXT  8  4.65 
AMP, AMC, FOX, TET  7  4.07 
AMP, AMC, FOX  6  3.49 
AMP, AMC, TET  5  2.91 
AMP, SXT  5  2.91 
AMP, AMC  4  2.33 
AMP, AMC, FOX, CEPH3, ATM  4  2.33 
AMP, AMC, FOX, CEPH3, CPO, ATM  4  2.33 
AMP, FOX, SXT  2  1.16 
AMP, AMC, FOX, CEPH3, CARB, SXT  2  1.16 
AMP, AMC, FOX, CEPH3, SXT  2  1.16 
AMP, AMC, FOX, CEPH3, CPO, CARB, SXT  2  1.16 
AMP, AMC, FOX, SXT  2  1.16 
Others with only one representative  8  4.64 
Sub-Total   118  68.60 
Total   172  100 
The most effective antimicrobial agents against the bacterial strains isolated are GEN (98.3%), CIP 
(97.7%), IPM (95.3%) and MEM (90.7%). It seems noteworthy the high bacterial susceptibility to CIP 
found since in Portugal, in contrast to other European countries, this type of antibiotics is one of the 
most frequently used [23]. The high frequency of resistance to AMC (51.7%) might be due to the their 
extensive usage in Europe, since penicillins represent the most widely used antibiotic class in all 25 
participating countries studied by Ferech et al. [24] in the ESAC Project Group. These authors 
reported a distinct shift from narrow-spectrum penicillins to broad-spectrum penicillins, and 
specifically their combinations with -lactamase inhibitors, during the period 1997-2003.  
On the other hand, the equally high resistance to FOX (46.5%) a cephamycin, is probably because it  
has been on the market for a longer period which may have allowed for the development of more 
resistance than those that are more recently available [25]. The shifting in antibiotic use in Europe is 
extremely high for this class of antibiotics, suggesting that in many European countries these 
antibiotics are prescribed inappropriately [25]. 
The high resistance detected to TET (46.5%) may be related with their extensive use in veterinary, 
[26-29] including aquacultures. Nevertheless, it could also mean an eventual non efficiency in humans 
through selection, following the widespread use of these antibiotics [27].  
The most prevalent resistance phenotype is AMP + TET (11.0%) followed by the MDR phenotypes 
AMP + SXT + TET and AMP + AMC + FOX + SXT + TET (each 4.7%). This fact might result from 
the association of TET with the massive use of Bactrim (SXT) [30] mainly for the treatment of 
urinary infections [31]. Other sulfonamides are also described as widely used for both veterinary and Int. J. Mol. Sci. 2009, 10                 
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aquacultures purposes [27]. Among the MDR phenotypes, resistance to CHL was also present in 
important phenotypes such as AMP + AMC + FOX + CHL + TET (4.1%) and AMP + AMC + FOX 
+CHL + TET + SXT (2.3%) or AMP + AMC + FOX + CHL + SXT (2.3%).  
The relatively high number (31.4%) of MDR phenotypes found among bacteria isolated from 
different types of cheese, may contribute to the emergence of a serious public health problem. These 
finding are in agreement with the results of Fernandes et al. [32], that reported the spreading of MDR 
in hospitals and in the community by isolates of E. coli coding for ESBLs. The same effect was also 
reported in other European countries [32,33].  
3.5. Molecular genetics of resistance genes 
Twenty one randomly selected isolates were tested for the presence of three -lactamases genes. 
The expected sizes of these amplicons, according to the control strains used, were 445 bp for the 
blaTEM, 593 bp for the blaCTX-M and 747 bp for the blaSHV. The multiplex-PCR analysis showed that, 
while the blaCTX-M and blaSHV were absent, 80.9% of the tested isolates harbor a gene for the TEM-type 
enzyme (blaTEM). 
The presence of blaTEM in bacteria isolated from cheese reported in this study, is in agreement with 
several recent reports showing that TEM β-lactamases are particularly involved in resistance 
phenotypes presented by bacteria isolated from several agro-industrial environments such as in water 
reservoirs [34], wastewaters [35], livestock [36-39] and even in transgenic plant fields [40]. The 
presence of TEM β-lactamases in these bacteria may be explained by its insertion between 
transposable elements that move rapidly through bacterial populations [41] and may become a major 
public health concern. However, TEM-β-lactamases alone may not explain all the resistance 
phenotypes found in the present study. Regarding the results presented in Table 3, they may be 
explained by several other mechanisms that include the presence of other β-lactamases, alteration of 
membrane permeability such as due the presence of a porin loss, modification of target, efflux 
mechanisms. In what concerns to the mechanisms related to other antimicrobial rather than β-lactams 
the mechanisms that may explain these resistance phenotype are identical [5,6]. In order to clarify this 
subject, further studies are needed. 
4. Conclusions  
Aiming to investigate the role of the consumption of a RTE type of food (cheese) in the transfer of 
β-lactams-resistant bacteria to the gastrointestinal (GI) flora of the consumer, twenty cheese samples 
were analysed. These samples corresponded to six different types of Portuguese ripened cheese, 
collected from retail market at different geographical regions of Portugal.  
The numbers of AMP
r bacteria recovered from the cheeses varied from 4.7  10
2 CFU/g to 1.5  
10
7 CFU/g. Since 85% of the selected isolates were identified as belonging to the Enterobacteriaceae 
family, the highest counting values obtained (particularly cheese types B and C) suggest the absence of 
good sanitary conditions during milking and/or cheesemaking. This fact is of considerable public 
health concern, particularly because the nitrocefine test indicated the presence of -lactamases in 94.5 
% of the AMP
r isolates. The multiplex PCR assay indicated a high prevalence (80.9%) of the blaTEM 
gene among the tested isolates. The antimicrobial susceptibility testing values and the resistance Int. J. Mol. Sci. 2009, 10                 
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phenotypes found among the isolates may be of clinical relevance if the resistance determinants could 
be transferred to humans. Transfer of either antibiotic-resistant bacteria to humans or of their antibiotic 
resistance genes to pathogens, via the food chain has already been reported [42-44].  
Resistance to antibiotics is a major public-health problem and antibiotic use is being increasingly 
recognised as the main selective pressure driving this resistance [45]. Prescription of antibiotics in 
primary care in Europe varied greatly nevertheless, a shift was recently noted in the consumption of 
antibiotics from the old narrow-spectrum antibiotics to the new broad-spectrum antibiotics. High 
consuming countries showed higher rates of antibiotic resistance, probably related to the higher 
consumption in Southern and Eastern Europe than in Northern Europe [45]. 
To our knowledge, this is the first report in Portugal of the presence of β-lactam resistance bacteria 
in cheese. The results suggest the importance of good hygienic practices during milking and 
cheesemaking, particularly when the cheese is made from raw milk. In the genome of the carrier 
bacteria, the localization of the β-lactamase genes needs to be elucidated in order to predict their 
possibility of transfer to the consumer GI flora. 
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